10 Aug Hope versus experience in glioblastoma
Development of new drugs for this hard-to-treat brain cancer is a slow and incremental process....
News
13 Jul Investment in Spanish biotech is at an all-time high
The Spanish Bioindustry Association (AseBio), where Laminar Pharma is a member, has published its latest annual report on the state of the biotech sector in Spain, with updated data from 2020. ...
05 May Laminar partners with charity Sonrisa Médica to bring joy to hospitalised children
Laminar Pharma has signed an agreement to sponsor the charity Sonrisa Médica, whose mission is to make hospital stays bearable for children, through laughter and magic....
23 Mar Meet the CEO: Dr. Pablo Escribá
“If someone has done it before, I can do it too – if no one has done it, I can be the first”: for 30 years, this compass has guided the prolific scientific career of Dr. Pablo Escribá, founder and CEO of Laminar Pharma....
10 Mar We have joined The Universidad de Alicante Science Park
Alicante Science Park Foundation (PCA) and Laminar Pharmaceuticals have signed today the contract by which the biotechnology company is linked to the PCA....
10 Mar Our researcher Gema Malet receives an individual Marie Skłodowska-Curie grant in recognition for excellent professional development
In 2020, biologist Gema Malet Engra joined our company after a successful 15-year career in fundamental and applied research in Oncology at several international research centers. ...
03 Mar Rare Disease Day 2021: commitment to patients is commitment to scientific research
On the last day of February — a month known for having a ‘rare’ number of days — we commemorate Rare Disease Day to celebrate their strength, to share their stories and to champion research that will improve these patients’ lives....
12 Feb Ramón Roldán joins Laminar Pharma with a postdoctoral project to isolate protumoral proteins
On January 2021, the researchers whose projects have received funding from the CAIB 2020 call of the Balearic Government for the promotion of hiring of research staff were announced: Ramón Román Roldán has been selected, and he will join the Research Unit of Laminar Pharma....
18 Jan Social businesses are changing the world
Society needs social change agents who are committed to creating a better world than the one they found. ...
10 Dec We’re finalists in the 5th CAEB Santander Awards for Business Innovation
The ceremony for the 5th edition of the Awards of the Confederation of Business Associations of the Balearic Islands (CAEB), called CAEB SANTANDER, was held today in Palma de Mallorca, to recognize the business innovation of small and medium-sized companies....
- 1
- 2